{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T15:26:29Z","timestamp":1792682789151,"version":"4.5.0"},"reference-count":102,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T00:00:00Z","timestamp":1761696000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["CRC1080"],"award-info":[{"award-number":["CRC1080"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004543","name":"China Scholarship Council","doi-asserted-by":"publisher","award":["CRC1080C02"],"award-info":[{"award-number":["CRC1080C02"]}],"id":[{"id":"10.13039\/501100004543","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004543","name":"China Scholarship Council","doi-asserted-by":"publisher","award":["SCHA1261\/4 \\u2212 3"],"award-info":[{"award-number":["SCHA1261\/4 \\u2212 3"]}],"id":[{"id":"10.13039\/501100004543","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.neurot.2025.e00787","type":"journal-article","created":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T03:11:40Z","timestamp":1762571500000},"page":"e00787","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["CSF1R and IL1R1 inhibitors synergistically attenuate the early pathogenesis of traumatic brain injury in mice"],"prefix":"10.1016","volume":"23","author":[{"given":"Sudena","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny","family":"Strehle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isa","family":"Wernersbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ermis","family":"Papakonstantinou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pawit","family":"Somnuke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Ritter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irmgard","family":"Tegeder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6055-6244","authenticated-orcid":false,"given":"Michael K.E.","family":"Sch\u00e4fer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurot.2025.e00787_bib1","first-page":"1","article-title":"Estimating the global incidence of traumatic brain injury","author":"Dewan","year":"2018","journal-title":"J Neurosurg"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00787_bib2","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12868-024-00851-6","article-title":"Current state of neuroprotective therapy using antibiotics in human traumatic brain injury and animal models","volume":"25","author":"Ritter","year":"2024","journal-title":"BMC Neurosci"},{"issue":"5","key":"10.1016\/j.neurot.2025.e00787_bib3","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3390\/medicines11050010","article-title":"A modern approach to the treatment of traumatic brain injury","volume":"11","author":"Syzdykbayev","year":"2024","journal-title":"Medicines"},{"issue":"26","key":"10.1016\/j.neurot.2025.e00787_bib4","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1056\/NEJMoa1404304","article-title":"Very early administration of progesterone for acute traumatic brain injury","volume":"371","author":"Wright","year":"2014","journal-title":"N Engl J Med"},{"issue":"10012","key":"10.1016\/j.neurot.2025.e00787_bib5","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1016\/S0140-6736(15)00386-4","article-title":"Erythropoietin in traumatic brain injury (EPO-TBI): a double-blind randomised controlled trial","volume":"386","author":"Nichol","year":"2015","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00787_bib6","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1093\/bja\/aem131","article-title":"Pathophysiology of traumatic brain injury","volume":"99","author":"Werner","year":"2007","journal-title":"Br J Anaesth"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00787_bib7","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s00441-014-1807-y","article-title":"Regulators of mitochondrial Ca(2+) homeostasis in cerebral ischemia","volume":"357","author":"Sch\u00e4fer","year":"2014","journal-title":"Cell Tissue Res"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00787_bib8","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1007\/s13311-020-00840-7","article-title":"Cell death and recovery in traumatic brain injury","volume":"17","author":"Akamatsu","year":"2020","journal-title":"Neurotherapeutics"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00787_bib9","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1007\/s12035-014-8752-3","article-title":"Interactions of oxidative stress and neurovascular inflammation in the pathogenesis of traumatic brain injury","volume":"51","author":"Abdul-Muneer","year":"2015","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.neurot.2025.e00787_bib10","doi-asserted-by":"crossref","first-page":"208","DOI":"10.3389\/fnagi.2017.00208","article-title":"Microglial activation in traumatic brain injury","volume":"9","author":"Donat","year":"2017","journal-title":"Front Aging Neurosci"},{"issue":"5","key":"10.1016\/j.neurot.2025.e00787_bib11","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1007\/s00401-018-1944-6","article-title":"The complexity of neuroinflammation consequent to traumatic brain injury: from research evidence to potential treatments","volume":"137","author":"Morganti-Kossmann","year":"2019","journal-title":"Acta Neuropathol"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00787_bib12","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1007\/s11033-024-09995-4","article-title":"Microglia-mediated neuroinflammation in traumatic brain injury: a review","volume":"51","author":"Obukohwo","year":"2024","journal-title":"Mol Biol Rep"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00787_bib13","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.neuron.2014.02.040","article-title":"Colony-stimulating factor 1 receptor signaling is necessary for microglia viability, unmasking a microglia progenitor cell in the adult brain","volume":"82","author":"Elmore","year":"2014","journal-title":"Neuron"},{"issue":"9","key":"10.1016\/j.neurot.2025.e00787_bib14","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.it.2020.07.001","article-title":"To kill a microglia: a case for CSF1R inhibitors","volume":"41","author":"Green","year":"2020","journal-title":"Trends Immunol"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00787_bib15","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/glia.23529","article-title":"Enforced microglial depletion and repopulation as a promising strategy for the treatment of neurological disorders","volume":"67","author":"Han","year":"2019","journal-title":"Glia"},{"key":"10.1016\/j.neurot.2025.e00787_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2023.108565","article-title":"Repurposing of pexidartinib for microglia depletion and renewal","volume":"253","author":"Weyer","year":"2024","journal-title":"Pharmacol Therapeut"},{"issue":"6","key":"10.1016\/j.neurot.2025.e00787_bib17","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a021857","article-title":"CSF-1 receptor signaling in Myeloid cells","volume":"6","author":"Stanley","year":"2014","journal-title":"Cold Spring Harbor Perspect Biol"},{"key":"10.1016\/j.neurot.2025.e00787_bib18","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2024.1352790","article-title":"Deplete and repeat: microglial CSF1R inhibition and traumatic brain injury","volume":"18","author":"Boland","year":"2024","journal-title":"Front Cell Neurosci"},{"issue":"14","key":"10.1016\/j.neurot.2025.e00787_bib19","doi-asserted-by":"crossref","first-page":"2960","DOI":"10.1523\/JNEUROSCI.2402-19.2020","article-title":"Microglial depletion with CSF1R inhibitor during chronic phase of experimental traumatic brain injury reduces neurodegeneration and neurological deficits","volume":"40","author":"Henry","year":"2020","journal-title":"J Neurosci: Off J Soc Neurosci"},{"issue":"20","key":"10.1016\/j.neurot.2025.e00787_bib20","doi-asserted-by":"crossref","first-page":"4215","DOI":"10.1523\/JNEUROSCI.1910-21.2022","article-title":"Chronic cortical inflammation, cognitive impairment and immune reactivity associated with diffuse brain injury are ameliorated by forced turnover of microglia","volume":"42","author":"Bray","year":"2022","journal-title":"J Neurosci: Off J Soc Neurosci"},{"key":"10.1016\/j.neurot.2025.e00787_bib21","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.bbi.2022.07.164","article-title":"Early posttraumatic CSF1R inhibition via PLX3397 leads to time- and sex-dependent effects on inflammation and neuronal maintenance after traumatic brain injury in mice","volume":"106","author":"Wang","year":"2022","journal-title":"Brain Behav Immun"},{"issue":"105","key":"10.1016\/j.neurot.2025.e00787_bib22","first-page":"cm1","article-title":"Interleukin-1 (IL-1) pathway","volume":"3","author":"Weber","year":"2010","journal-title":"Sci Signal"},{"key":"10.1016\/j.neurot.2025.e00787_bib23","doi-asserted-by":"crossref","first-page":"287","DOI":"10.3389\/fnbeh.2019.00287","article-title":"Contributions of Interleukin-1 receptor signaling in traumatic brain injury","volume":"13","author":"Thome","year":"2019","journal-title":"Front Behav Neurosci"},{"key":"10.1016\/j.neurot.2025.e00787_bib24","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.688254","article-title":"Inflammatory regulation of CNS barriers after traumatic brain injury: a tale directed by Interleukin-1","volume":"12","author":"Bodnar","year":"2021","journal-title":"Front Immunol"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00787_bib25","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21020387","article-title":"Interleukin-1 beta neutralization attenuates traumatic brain injury-induced microglia activation and neuronal changes in the globus pallidus","volume":"21","author":"Ozen","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.neurot.2025.e00787_bib26","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1742-2094-3-15","article-title":"Astrogliosis is delayed in type 1 interleukin-1 receptor-null mice following a penetrating brain injury","volume":"3","author":"Lin","year":"2006","journal-title":"J Neuroinflammation"},{"issue":"23","key":"10.1016\/j.neurot.2025.e00787_bib27","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1089\/neu.2018.5660","article-title":"Neutralization of Interleukin-1\u03b2 following diffuse traumatic brain injury in the mouse attenuates the loss of mature oligodendrocytes","volume":"35","author":"Flygt","year":"2018","journal-title":"J Neurotrauma"},{"issue":"6","key":"10.1016\/j.neurot.2025.e00787_bib28","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1007\/s13311-023-01421-0","article-title":"Interleukin-1 receptor antagonist as therapy for traumatic brain injury","volume":"20","author":"Lindblad","year":"2023","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.neurot.2025.e00787_bib29","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.888392","article-title":"Systematic review of safety and efficacy of IL-1-Targeted biologics in treating immune-mediated disorders","volume":"13","author":"Arnold","year":"2022","journal-title":"Front Immunol"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00787_bib30","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1002\/art.10870","article-title":"Anakinra, a recombinant human interleukin-1 receptor antagonist (r-metHuIL-1ra), in patients with rheumatoid arthritis: a large, international, multicenter, placebo-controlled trial","volume":"48","author":"Fleischmann","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.neurot.2025.e00787_bib31","doi-asserted-by":"crossref","DOI":"10.1177\/1759720X20959575","article-title":"The off-label use of anakinra in pediatric systemic autoinflammatory diseases","volume":"12","author":"Maniscalco","year":"2020","journal-title":"Ther Adv Musculoskelet Dis"},{"issue":"6","key":"10.1016\/j.neurot.2025.e00787_bib32","doi-asserted-by":"crossref","first-page":"e358","DOI":"10.1016\/S2665-9913(20)30096-5","article-title":"Silencing the cytokine storm: the use of intravenous anakinra in haemophagocytic lymphohistiocytosis or macrophage activation syndrome","volume":"2","author":"Mehta","year":"2020","journal-title":"Lancet Rheumatol"},{"key":"10.1016\/j.neurot.2025.e00787_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2023.156311","article-title":"A meta analysis on the utility of Anakinra in severe COVID-19 disease","volume":"169","author":"Mohamed Hussein","year":"2023","journal-title":"Cytokine"},{"issue":"5","key":"10.1016\/j.neurot.2025.e00787_bib34","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/jcbfm.2014.23","article-title":"Recombinant human interleukin-1 receptor antagonist in severe traumatic brain injury: a phase II randomized control trial","volume":"34","author":"Helmy","year":"2014","journal-title":"J Cerebr Blood Flow Metabol"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00787_bib35","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/jnr.23617","article-title":"Inflammatory cytokine receptor blockade in a rodent model of mild traumatic brain injury","volume":"94","author":"Perez-Polo","year":"2016","journal-title":"J Neurosci Res"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00787_bib36","doi-asserted-by":"crossref","DOI":"10.1523\/ENEURO.0385-17.2018","article-title":"Combined blockade of Interleukin-1\u03b1 and -1\u03b2 signaling protects mice from cognitive dysfunction after traumatic brain injury","volume":"5","author":"Newell","year":"2018","journal-title":"eNeuro"},{"key":"10.1016\/j.neurot.2025.e00787_bib37","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.bbi.2017.08.005","article-title":"Treatment with an interleukin-1 receptor antagonist mitigates neuroinflammation and brain damage after polytrauma","volume":"66","author":"Sun","year":"2017","journal-title":"Brain Behav Immun"},{"issue":"12","key":"10.1016\/j.neurot.2025.e00787_bib38","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1089\/neu.2019.6725","article-title":"Modulation of post-traumatic immune response using the IL-1 receptor antagonist anakinra for improved visual outcomes","volume":"37","author":"Evans","year":"2020","journal-title":"J Neurotrauma"},{"issue":"10","key":"10.1016\/j.neurot.2025.e00787_bib39","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0026317","article-title":"Absence of colony stimulation factor-1 receptor results in loss of microglia, disrupted brain development and olfactory deficits","volume":"6","author":"Erblich","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.neurot.2025.e00787_bib40","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/8835730","article-title":"Early reciprocal effects in a murine model of traumatic brain injury and femoral fracture","volume":"2021","author":"Ritter","year":"2021","journal-title":"Mediat Inflamm"},{"issue":"22","key":"10.1016\/j.neurot.2025.e00787_bib41","doi-asserted-by":"crossref","first-page":"5208","DOI":"10.1111\/bph.15259","article-title":"Administration of all-trans retinoic acid after experimental traumatic brain injury is brain protective","volume":"177","author":"Hummel","year":"2020","journal-title":"Br J Pharmacol"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00787_bib42","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1186\/s12974-024-03249-7","article-title":"Selective neuronal expression of progranulin is sufficient to provide neuroprotective and anti-inflammatory effects after traumatic brain injury","volume":"21","author":"Wang","year":"2024","journal-title":"J Neuroinflammation"},{"issue":"13","key":"10.1016\/j.neurot.2025.e00787_bib43","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1038\/npp.2012.152","article-title":"Candesartan, an angiotensin II AT1-Receptor blocker and PPAR-\u03b3 agonist, reduces lesion volume and improves motor and memory function after traumatic brain injury in mice","volume":"37","author":"Villapol","year":"2012","journal-title":"Neuropsychopharmacology"},{"issue":"43","key":"10.1016\/j.neurot.2025.e00787_bib44","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neurot.2025.e00787_bib45","first-page":"12","article-title":"Modified protocol to enable the study of hemorrhage and hematoma in a traumatic brain injury mouse model","author":"Joo","year":"2021","journal-title":"Front Neurol"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00787_bib46","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1111\/jon.13115","article-title":"Ultrasound, photoacoustic, and magnetic resonance imaging to study hyperacute pathophysiology of traumatic and vascular brain injury","volume":"33","author":"Kamali","year":"2023","journal-title":"J Neuroimag"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00787_bib47","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/jnr.24415","article-title":"Noninvasive magnetic resonance imaging stratifies injury severity in a rodent model of male juvenile traumatic brain injury","volume":"98","author":"Badaut","year":"2020","journal-title":"J Neurosci Res"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00787_bib48","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1097\/CCM.0000000000005749","article-title":"Precision effects of glibenclamide on MRI endophenotypes in clinically relevant Murine Traumatic Brain injury","volume":"51","author":"Zusman","year":"2023","journal-title":"Crit Care Med"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00787_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.115176","article-title":"The microglial response to inhibition of Colony-stimulating-factor-1 receptor by PLX3397 differs by sex in adult mice","volume":"44","author":"Le","year":"2025","journal-title":"Cell Rep"},{"key":"10.1016\/j.neurot.2025.e00787_bib50","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.3389\/fimmu.2019.02199","article-title":"CSF1R ligands IL-34 and CSF1 are differentially required for Microglia development and maintenance in white and gray matter brain regions","volume":"10","author":"Easley-Neal","year":"2019","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00787_bib51","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/s41467-022-35753-w","article-title":"CSF1R inhibitors induce a sex-specific resilient microglial phenotype and functional rescue in a tauopathy mouse model","volume":"14","author":"Johnson","year":"2023","journal-title":"Nat Commun"},{"issue":"9","key":"10.1016\/j.neurot.2025.e00787_bib52","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1002\/glia.23171","article-title":"Sexual dimorphism in the inflammatory response to traumatic brain injury","volume":"65","author":"Villapol","year":"2017","journal-title":"Glia"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00787_bib53","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/jnc.14678","article-title":"Sex hormones modulate pathogenic processes in experimental traumatic brain injury","volume":"150","author":"G\u00f6lz","year":"2019","journal-title":"J Neurochem"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00787_bib54","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1007\/s12031-018-1038-x","article-title":"Endogenous sex steroids dampen neuroinflammation and improve outcome of traumatic brain injury in mice","volume":"64","author":"Clevenger","year":"2018","journal-title":"J Mol Neurosci"},{"issue":"7","key":"10.1016\/j.neurot.2025.e00787_bib55","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1089\/neu.2018.6019","article-title":"Sex differences in acute neuroinflammation after experimental traumatic Brain injury are mediated by infiltrating Myeloid cells","volume":"36","author":"Doran","year":"2019","journal-title":"J Neurotrauma"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00787_bib56","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.immuni.2018.12.012","article-title":"Cell-Type-Specific interleukin 1 receptor 1 signaling in the brain regulates distinct neuroimmune activities","volume":"50","author":"Liu","year":"2019","journal-title":"Immunity"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00787_bib57","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.bbi.2004.06.001","article-title":"IL-1 type I receptor plays a key role in mediating the recruitment of leukocytes into the central nervous system","volume":"19","author":"Ching","year":"2005","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.neurot.2025.e00787_bib58","first-page":"12","article-title":"Immune response in neurological pathology: emerging role of central and peripheral immune crosstalk","author":"Passaro","year":"2021","journal-title":"Front Immunol"},{"issue":"8","key":"10.1016\/j.neurot.2025.e00787_bib59","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1038\/nm.1999","article-title":"Pivotal role of cerebral interleukin-17-producing gammadeltaT cells in the delayed phase of ischemic brain injury","volume":"15","author":"Shichita","year":"2009","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00787_bib60","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1186\/s12974-016-0663-y","article-title":"Cortisol-induced immune suppression by a blockade of lymphocyte egress in traumatic brain injury","volume":"13","author":"Dong","year":"2016","journal-title":"J Neuroinflammation"},{"issue":"18","key":"10.1016\/j.neurot.2025.e00787_bib61","doi-asserted-by":"crossref","first-page":"3835","DOI":"10.1182\/blood-2009-10-249078","article-title":"Early detrimental T-cell effects in experimental cerebral ischemia are neither related to adaptive immunity nor thrombus formation","volume":"115","author":"Kleinschnitz","year":"2010","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00787_bib62","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1186\/s12974-019-1550-0","article-title":"Depletion of regulatory T cells increases T cell brain infiltration, reactive astrogliosis, and interferon-\u03b3 gene expression in acute experimental traumatic brain injury","volume":"16","author":"Kr\u00e4mer","year":"2019","journal-title":"J Neuroinflammation"},{"issue":"7","key":"10.1016\/j.neurot.2025.e00787_bib63","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.1073\/pnas.1315943111","article-title":"Ischemic neurons recruit natural killer cells that accelerate brain infarction","volume":"111","author":"Gan","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"issue":"11","key":"10.1016\/j.neurot.2025.e00787_bib64","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1007\/s11064-015-1714-y","article-title":"Proteinase 3 induces neuronal cell death through microglial activation","volume":"40","author":"Cho","year":"2015","journal-title":"Neurochem Res"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00787_bib65","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/s12974-017-0908-4","article-title":"Amplification and propagation of interleukin-1\u03b2 signaling by murine brain endothelial and glial cells","volume":"14","author":"Krasnow","year":"2017","journal-title":"J Neuroinflammation"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00787_bib66","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1186\/s12974-023-02934-3","article-title":"IL-1R1 signaling in TBI: assessing chronic impacts and neuroinflammatory dynamics in a mouse model of mild closed-head injury","volume":"20","author":"Vincent","year":"2023","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.neurot.2025.e00787_bib67","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1283711","article-title":"Limitations of PLX3397 as a microglial investigational tool: peripheral and off-target effects dictate the response to inflammation","volume":"14","author":"Claeys","year":"2023","journal-title":"Front Immunol"},{"issue":"6","key":"10.1016\/j.neurot.2025.e00787_bib68","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1084\/jem.20151437","article-title":"Myeloid cell transmigration across the CNS vasculature triggers IL-1\u03b2\u2013driven neuroinflammation during autoimmune encephalomyelitis in mice","volume":"213","author":"L\u00e9vesque","year":"2016","journal-title":"J Exp Med"},{"key":"10.1016\/j.neurot.2025.e00787_bib69","article-title":"Transport study of interleukin-1 inhibitors using a human in vitro model of the blood-brain barrier","volume":"16","author":"Sj\u00f6str\u00f6m","year":"2021","journal-title":"Brain Behav Immun Health"},{"issue":"12","key":"10.1016\/j.neurot.2025.e00787_bib70","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109727","article-title":"CCR2 deficiency alters activation of microglia subsets in traumatic brain injury","volume":"36","author":"Somebang","year":"2021","journal-title":"Cell Rep"},{"issue":"12","key":"10.1016\/j.neurot.2025.e00787_bib71","article-title":"STING-Dependent signaling in microglia or peripheral immune cells orchestrates the early inflammatory response and influences brain injury outcome","volume":"44","author":"Fritsch","year":"2024","journal-title":"J Neurosci"},{"key":"10.1016\/j.neurot.2025.e00787_bib72","doi-asserted-by":"crossref","first-page":"458","DOI":"10.3389\/fneur.2018.00458","article-title":"Interferons in traumatic brain and spinal cord injury: current evidence for translational application","volume":"9","author":"Roselli","year":"2018","journal-title":"Front Neurol"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00787_bib73","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/s40478-023-01635-5","article-title":"Selective neuroimmune modulation by type I interferon drives neuropathology and neurologic dysfunction following traumatic brain injury","volume":"11","author":"Todd","year":"2023","journal-title":"Acta Neuropatho Commun"},{"issue":"11","key":"10.1016\/j.neurot.2025.e00787_bib74","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1523\/JNEUROSCI.2516-19.2020","article-title":"Interferon-\u03b2 plays a detrimental role in experimental traumatic brain injury by enhancing neuroinflammation that drives chronic neurodegeneration","volume":"40","author":"Barrett","year":"2020","journal-title":"J Neurosci"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00787_bib75","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1186\/s12974-021-02197-w","article-title":"Traumatic brain injury results in unique microglial and astrocyte transcriptomes enriched for type I interferon response","volume":"18","author":"Todd","year":"2021","journal-title":"J Neuroinflammation"},{"issue":"7","key":"10.1016\/j.neurot.2025.e00787_bib76","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1523\/JNEUROSCI.2469-20.2020","article-title":"Traumatic brain injury causes chronic cortical inflammation and neuronal dysfunction mediated by Microglia","volume":"41","author":"Witcher","year":"2021","journal-title":"J Neurosci"},{"key":"10.1016\/j.neurot.2025.e00787_bib77","article-title":"Type I interferon response is mediated by NLRX1-cGAS-STING signaling in brain injury","volume":"15","author":"Fritsch","year":"2022","journal-title":"Front Mol Neurosci"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00787_bib78","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1186\/s12974-018-1354-7","article-title":"STING-mediated type-I interferons contribute to the neuroinflammatory process and detrimental effects following traumatic brain injury","volume":"15","author":"Abdullah","year":"2018","journal-title":"J Neuroinflammation"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00787_bib79","doi-asserted-by":"crossref","DOI":"10.1523\/ENEURO.0128-15.2016","article-title":"Ablation of Type-1 IFN signaling in hematopoietic cells confers protection following traumatic brain injury","volume":"3","author":"Karve","year":"2016","journal-title":"eNeuro"},{"issue":"48","key":"10.1016\/j.neurot.2025.e00787_bib80","doi-asserted-by":"crossref","first-page":"9082","DOI":"10.1523\/JNEUROSCI.1377-22.2022","article-title":"Amplified gliosis and interferon-associated inflammation in the aging brain following diffuse traumatic brain injury","volume":"42","author":"Wangler","year":"2022","journal-title":"J Neurosci"},{"issue":"10","key":"10.1016\/j.neurot.2025.e00787_bib81","doi-asserted-by":"crossref","first-page":"2939","DOI":"10.1007\/s00221-021-06178-6","article-title":"Animal models of traumatic brain injury: a review of pathophysiology to biomarkers and treatments","volume":"239","author":"Petersen","year":"2021","journal-title":"Exp Brain Res"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00787_bib82","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/nrn3407","article-title":"Animal models of traumatic brain injury","volume":"14","author":"Xiong","year":"2013","journal-title":"Nat Rev Neurosci"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00787_bib83","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1089\/neu.2019.6675","article-title":"A mouse model for juvenile, lateral fluid percussion brain injury reveals sex-dependent differences in neuroinflammation and functional recovery","volume":"37","author":"Newell","year":"2020","journal-title":"J Neurotrauma"},{"issue":"18","key":"10.1016\/j.neurot.2025.e00787_bib84","doi-asserted-by":"crossref","first-page":"3069","DOI":"10.1016\/j.neuron.2024.06.021","article-title":"A single-cell atlas deconstructs heterogeneity across multiple models in murine traumatic brain injury and identifies novel cell-specific targets","volume":"112","author":"Jha","year":"2024","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00787_bib85","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1089\/neur.2024.0074","article-title":"Old age exacerbates white matter neuroinflammation and cognitive deficits following closed-head injury, particularly in female mice","volume":"5","author":"Macheda","year":"2024","journal-title":"Neurotrauma Rep"},{"key":"10.1016\/j.neurot.2025.e00787_bib86","first-page":"5","article-title":"Molecular mechanisms of cognitive dysfunction following traumatic brain injury","author":"Walker","year":"2013","journal-title":"Front Aging Neurosci"},{"issue":"13-14","key":"10.1016\/j.neurot.2025.e00787_bib87","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1089\/neu.2022.0360","article-title":"Lifetime traumatic brain injury and cognitive domain deficits in late life: the PROTECT-TBI cohort study","volume":"40","author":"Lennon","year":"2023","journal-title":"J Neurotrauma"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00787_bib88","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.bja.2019.02.032","article-title":"Xenon improves long-term cognitive function, reduces neuronal loss and chronic neuroinflammation, and improves survival after traumatic brain injury in mice","volume":"123","author":"Campos-Pires","year":"2019","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.neurot.2025.e00787_bib89","doi-asserted-by":"crossref","DOI":"10.1007\/s00429-017-1452-9","article-title":"Traumatic brain injury causes long-term behavioral changes related to region-specific increases of cerebral blood flow","author":"P\u00f6ttker","year":"2017","journal-title":"Brain Struct Funct"},{"issue":"19-20","key":"10.1016\/j.neurot.2025.e00787_bib90","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1089\/neu.2022.0015","article-title":"Chronic cognitive and cerebrovascular function after mild traumatic brain injury in rats","volume":"39","author":"Griffiths","year":"2022","journal-title":"J Neurotrauma"},{"key":"10.1016\/j.neurot.2025.e00787_bib91","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2021.636259","article-title":"Transcriptomic analysis of mouse brain after traumatic brain injury reveals that the angiotensin receptor blocker candesartan acts through novel pathways","volume":"15","author":"Attilio","year":"2021","journal-title":"Front Neurosci"},{"key":"10.1016\/j.neurot.2025.e00787_bib92","doi-asserted-by":"crossref","DOI":"10.1038\/srep31570","article-title":"Analysis of post-traumatic brain injury gene expression signature reveals tubulins, Nfe2l2, Nfkb, Cd44, and S100a4 as treatment targets","volume":"6","author":"Lipponen","year":"2016","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00787_bib93","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s40478-018-0519-z","article-title":"Transcription factors Tp73, Cebpd, Pax6, and Spi1 rather than DNA methylation regulate chronic transcriptomics changes after experimental traumatic brain injury","volume":"6","author":"Lipponen","year":"2018","journal-title":"Acta Neuropathol Commun"},{"issue":"9","key":"10.1016\/j.neurot.2025.e00787_bib94","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1007\/s00018-022-04495-9","article-title":"Systems spatiotemporal dynamics of traumatic brain injury at single-cell resolution reveals humanin as a therapeutic target","volume":"79","author":"Arneson","year":"2022","journal-title":"Cell Mol Life Sci"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00787_bib95","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22010045","article-title":"Initiators of classical and Lectin complement pathways are differently engaged after traumatic brain injury-time-dependent changes in the cortex, striatum, thalamus and hippocampus in a mouse model","volume":"22","author":"Ciechanowska","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00787_bib96","doi-asserted-by":"crossref","first-page":"6289","DOI":"10.1038\/s41598-022-10419-1","article-title":"Time dependent analysis of rat microglial surface markers in traumatic brain injury reveals dynamics of distinct cell subpopulations","volume":"12","author":"Gottlieb","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.neurot.2025.e00787_bib97","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jss.2019.08.024","article-title":"Microglia adopt longitudinal transcriptional changes after traumatic brain injury","volume":"246","author":"Makinde","year":"2020","journal-title":"J Surg Res"},{"issue":"19","key":"10.1016\/j.neurot.2025.e00787_bib98","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1089\/neu.2015.4268","article-title":"Microglial\/macrophage polarization dynamics following traumatic brain injury","volume":"33","author":"Kumar","year":"2016","journal-title":"J Neurotrauma"},{"key":"10.1016\/j.neurot.2025.e00787_bib99","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.bbi.2018.03.033","article-title":"Cellular players that shape evolving pathology and neurodegeneration following traumatic brain injury","volume":"71","author":"Puntambekar","year":"2018","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.neurot.2025.e00787_bib100","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2021.635483","article-title":"Drug repurposing in the treatment of traumatic brain injury","volume":"15","author":"Ghiam","year":"2021","journal-title":"Front Neurosci"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00787_bib101","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1089\/neu.2014.3855","article-title":"Combination therapies for traumatic brain injury: retrospective considerations","volume":"33","author":"Margulies","year":"2016","journal-title":"J Neurotrauma"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00787_bib102","doi-asserted-by":"crossref","first-page":"484","DOI":"10.2174\/1570159X15666170828165711","article-title":"Combination therapy for multi-target manipulation of secondary brain injury mechanisms","volume":"16","author":"Somayaji","year":"2018","journal-title":"Curr Neuropharmacol"}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S187874792500265X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S187874792500265X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T07:48:45Z","timestamp":1778831325000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S187874792500265X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":102,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S187874792500265X"],"URL":"https:\/\/doi.org\/10.1016\/j.neurot.2025.e00787","relation":{},"ISSN":["1878-7479"],"issn-type":[{"value":"1878-7479","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CSF1R and IL1R1 inhibitors synergistically attenuate the early pathogenesis of traumatic brain injury in mice","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurot.2025.e00787","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of American Society for Experimental NeuroTherapeutics.","name":"copyright","label":"Copyright"}],"article-number":"e00787"}}